Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association
Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a
patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a …
patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a …
[HTML][HTML] Blood pressure and the new ACC/AHA hypertension guidelines
JM Flack, B Adekola - Trends in cardiovascular medicine, 2020 - Elsevier
The ACC/AHA hypertension guidelines cover virtually all aspects of the diagnosis,
evaluation, monitoring, secondary causes as well as drug and non-drug treatment of …
evaluation, monitoring, secondary causes as well as drug and non-drug treatment of …
[HTML][HTML] Chlorthalidone vs. hydrochlorothiazide for hypertension–cardiovascular events
A Ishani, WC Cushman, SM Leatherman… - … England Journal of …, 2022 - Mass Medical Soc
Background Whether chlorthalidone is superior to hydrochlorothiazide for preventing major
adverse cardiovascular events in patients with hypertension is unclear. Methods In a …
adverse cardiovascular events in patients with hypertension is unclear. Methods In a …
[HTML][HTML] Chlorthalidone for hypertension in advanced chronic kidney disease
R Agarwal, AD Sinha, AE Cramer… - … England Journal of …, 2021 - Mass Medical Soc
Background Little evidence has been available to support the use of thiazide diuretics to
treat hypertension in patients with advanced chronic kidney disease. Methods We randomly …
treat hypertension in patients with advanced chronic kidney disease. Methods We randomly …
A randomized trial of intensive versus standard blood-pressure control
SPRINT Research Group - New England Journal of Medicine, 2015 - Mass Medical Soc
Background The most appropriate targets for systolic blood pressure to reduce
cardiovascular morbidity and mortality among persons without diabetes remain uncertain …
cardiovascular morbidity and mortality among persons without diabetes remain uncertain …
[HTML][HTML] 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial …
WT Ambrosius, KM Sink, CG Foy, DR Berlowitz… - Clinical …, 2014 - journals.sagepub.com
Background: High blood pressure is an important public health concern because it is highly
prevalent and a risk factor for adverse health outcomes, including coronary heart disease …
prevalent and a risk factor for adverse health outcomes, including coronary heart disease …
Treatment of resistant and refractory hypertension
MC Acelajado, ZH Hughes, S Oparil… - Circulation …, 2019 - Am Heart Assoc
Resistant hypertension (RHTN) is defined as uncontrolled blood pressure despite the use
of≥ 3 antihypertensive agents of different classes, including a diuretic, usually thiazide-like …
of≥ 3 antihypertensive agents of different classes, including a diuretic, usually thiazide-like …
Prevalence of resistant hypertension in the United States, 2003–2008
SD Persell - Hypertension, 2011 - Am Heart Assoc
The prevalence of resistant hypertension is unknown. Much previous knowledge comes
from referral populations or clinical trial participants. Using data from the National Health …
from referral populations or clinical trial participants. Using data from the National Health …
Hypertension in chronic kidney disease
SM Hamrahian, B Falkner - Hypertension: from basic research to clinical …, 2017 - Springer
Hypertension, a global public health problem, is currently the leading factor in the global
burden of disease. It is the major modifiable risk factor for heart disease, stroke and kidney …
burden of disease. It is the major modifiable risk factor for heart disease, stroke and kidney …